National and Kapodistrian University of Athens
Επίδραση της ολευρωπαΐνης στην χρόνια καρδιακή ανεπάρκεια που προκαλεί η χορήγηση της αδριαμυκίνης: μελέτη του μηχανισμού δράσης
Abstract
dc:descriptionIntroduction: Oleuropein (OLEU) is a natural phenolic antioxidant, which is present in elevated concentration in olives, olive oil and olive tree leaves conferring protection to the heart. Adriamycin (DXR) is one of the most effective chemotherapeutic agents but with a dose-dependent induction of cardiomyopathy and heart failure. The aim of the present study was to evaluate the effect of OLEU in DXR-induced heart failure in vivo.Methods: Ninety rats were randomly divided into 6 groups and treated as follows: Control group with no treatment, OLEU-1 and OLEU-2 groups, treated with 1000 and 2000 mg/Kg of OLEU respectively, given intraperitoneally (i.p.), for 14 consecutive days, DXR group treated with i.p. injection of 18mg/kg of DXR, divided into 6 equal doses and given over a period of 2 weeks, DXR-OLEU-1 and DXR-OLEU-2 groups, rats treated with OLEU and DXR for 14 days as previously described. At the end of the injection protocols the rats were anesthetized and subjected transthoracic echocardiographic examination (Vivid-i, GE Healthcare with a 12MHz probe). Then the rats were sacrificed and the hearts were rapidly excised for histological evaluation and immunohistochemical evaluation, while the remainder was used for the estimation of malondialdehyde (MDA) and protein carbonyls (PCs) as markers of oxidative stress, nitrotyrosine (NT) as index «nitrosative» stress, interleukin-6 (IL-6) and Big endothelin-1 (Big ET-1), which are important indicators of cardiac remodeling, eNOS and iNOS with Western-Blot method as inflammatory markers, AMPK and Akt with Western-Blot method as indicators of energy metabolism and apoptosis, respectively, and finally held and the identification of biomarkers and metabolites by NMR spectroscopy, which is a reliable method for the study of changes of the metabolic profiles of the cardiac cell. Results: Eighty two rats completed the study. The mortality in the DXR group was 19% by end of the injection protocol. Normal morphology of the cardiac tissue was seen in the Control group and in groups OLEU-1 and OLEU-2. Myocardium exhibited morphological changes in DXR group only including edema, chronic inflammation and degeneration of myocardial cells such as vacuolization. In the DXR-OLEU-1 and DXR-OLEU-2 groups mild hypertrophy without edema, inflammation and myocardial degeneration was observed. DXR induced a small decrease in wall thickness, a decrease in left ventricular (LV) mass, a decrease in fractional shortening (an index of systolic function), an increase in end-systolic LV diameter, and a trend towards adverse cardiac remodeling. Combined DXR-OLEU and OLEU alone groups did not cause any change and the animals did not differ from the normal Control. Furthermore, OLEU reduced oxidative and «nitrosative» stress, induced by the administration of DXR, and reduced the increased levels of Big ET-1 and IL-6 that inducing the expression of iNOS and result in myocardial suppression. The results of Western blot analysis demonstrate that the administration of DXR causes deactivation of Akt and AMPK kinases and eNOS synthase in the myocardium in relation to the group of Control. The results demonstrate the adverse effect of DXR in anti-apoptotic mechanisms (Akt), in cardiac energy metabolism (AMPK) and homeostasis NO, molecule important for normal cardiac function (eNOS). Moreover, studying and the other groups observe that both the group of DXR-OLEU-1 and the group of DXR-OLEU-2, the negative effects of DXR mitigated not only a very significant amount, but reversed, indicating thereby the preventive effect of the OLEU in DXR-induced heart failure. In particular, OLEU increased phosphorylation of three proteins, thereby contributing to good cardiac function and preventing the occurrence and development of irreversible heart failure. Finally, by applying statistical analysis of NMR spectra with principal components analysis (PCA) we observed a clear separation between the metabolic profile of the group of Control and the group of DXR. The metabolic profile of the groups that received OLEU and DXR seems to be approaching the group of Control. Studying metabolites of the group of DXR observed inhibition of aerobic glycolysis and oxidation of fatty acids that appears to be related to the inhibition of the activation of AMPK. Instead, the combination of the DXR and OLEU shown to prevents the disturbance of energy metabolism by DXR.Conclusion: The present study shows for the first time that the administration of OLEU in rats under DXR anticancer therapy has cardioprotective effect against induced heart failure. The underlying mechanism is complex and beyond the antioxidant activity include reducing the effects of adriamycin in very important for apoptosis, energy production and cardiac function proteins Akt, AMPK and eNOS respectively.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ioannidis, Konstantinos
- Ιωαννίδης, Κωνσταντίνος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36644